{"id":"W2339943063","doi":"10.1016/s1470-2045(16)00080-2","title":"Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":259,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"Ariad Pharmaceuticals","keywords":"Ponatinib; Medicine; Imatinib; Internal medicine; Myeloid leukemia; Imatinib mesylate; Oncology; Clinical trial; Clinical endpoint; Nilotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001946262,0.002114022,0.003700181,0.0003424553,0.000421213,0.001398516,0.0009461723,0.001742079,0.00657937],"category_scores_gemma":[0.002613864,0.00055399,0.002832915,0.0004846224,0.001424244,0.002176594,0.0006515087,0.00427088,0.001120925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009884142,"about_ca_system_score_gemma":0.001052658,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008079204,"about_ca_topic_score_gemma":0.002318675,"domain_scores_codex":[0.9990864,0.0004832871,0.00006130119,0.0001606031,0.00006709012,0.000141354],"domain_scores_gemma":[0.9989629,0.0003373433,0.0002340741,0.00008269498,0.00005226845,0.0003306522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9686752,0.001658546,0.000480454,0.001284926,0.00210727,0.00006762725,0.00008095389,0.0005991337,0.001656066,0.0002803355,0.001389066,0.02172039],"study_design_scores_gemma":[0.9776306,0.0188844,0.001025114,0.00004778013,0.0005819194,0.0000823647,0.00003365743,0.0002680377,0.000143987,0.0003769967,0.0009069225,0.00001826889],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9653817,0.01982013,0.001582693,0.002511382,0.001368021,0.003159296,0.001689781,0.0001952607,0.004291773],"genre_scores_gemma":[0.9821748,0.007073043,0.001587893,0.001739522,0.0003927189,0.00249522,0.001328175,0.000037004,0.00317158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00657937,"threshold_uncertainty_score":0.02201021,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1491709117621627,"score_gpt":0.447745619994161,"score_spread":0.2985747082319983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}